AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| DAV | Quarterly Activities Report | PRICE SENSITIVE | 24/04/18 | |
| DAV | Maiden JORC Potash Resource Update for Ebeleben Licence | PRICE SENSITIVE | 16/04/18 | |
| DAV | Historic Potash Resources for Muhlhausen Nohra Licences | PRICE SENSITIVE | 10/04/18 | |
| DAV | Inferred Resource Update - Johnnies Reward NT | PRICE SENSITIVE | 09/04/18 | |
| DAV | Conversion of First Milestone Shares and Appendix 3B | PRICE SENSITIVE | 04/04/18 | |
| DAV | Maiden JORC Potash Resource for Ebeleben Licence | PRICE SENSITIVE | 03/04/18 | |
| DAV | Maiden Gold-Copper Resource for Johnnies Reward, NT | PRICE SENSITIVE | 28/03/18 | |
| DAV Quarterly Activities Report | |||
| 24/04/18 | PRICE SENSITIVE | ||
| DAV Maiden JORC Potash Resource Update for Ebeleben Licence | |||
| 16/04/18 | PRICE SENSITIVE | ||
| DAV Historic Potash Resources for Muhlhausen Nohra Licences | |||
| 10/04/18 | PRICE SENSITIVE | ||
| DAV Inferred Resource Update - Johnnies Reward NT | |||
| 09/04/18 | PRICE SENSITIVE | ||
| DAV Conversion of First Milestone Shares and Appendix 3B | |||
| 04/04/18 | PRICE SENSITIVE | ||
| DAV Maiden JORC Potash Resource for Ebeleben Licence | |||
| 03/04/18 | PRICE SENSITIVE | ||
| DAV Maiden Gold-Copper Resource for Johnnies Reward, NT | |||
| 28/03/18 | PRICE SENSITIVE | ||
